Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Announcement & Circular
Stock Information
02186.HK
1.97 0.14  (7.65%)
Volume：130,198,500
06-16
2026
VOLUNTARY ANNOUNCEMENT THE PHASE 2 CLINICAL TRIAL IN CHINA OF THE GROUP'S NEW DRUG LY03015 (A VMAT2 INHIBITOR/SIGMA-1R AGONIST) FOR THE TREATMENT OF TARDIVE DYSKINESIA HAS ACHIEVED ...
Publisher：
06-11
2026
COMPLETION OF CONCURRENT REPURCHASE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028
Publisher：
06-11
2026
COMPLETION OF ISSUE OF US$180,000,000 5.25 PER CENT. CONVERTIBLE BONDS DUE 2031
Publisher：
06-08
2026
OVERSEAS REGULATORY ANNOUNCEMENT
Publisher：
06-04
2026
(1) PROPOSED CONCURRENT REPURCHASE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028; AND (2) PROPOSED ISSUE OF US$180,000,000 5.25 PER CENT. CONVERTIBLE BONDS DUE 2031
Publisher：
06-03
2026
(1) PROPOSED CONCURRENT REPURCHASE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028; AND (2) PROPOSED ISSUE OF USD-DENOMINATED CONVERTIBLE BONDS
Publisher：
06-03
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Publisher：
05-29
2026
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 26 JUNE 2026
Publisher：
05-29
2026
NOTICE OF ANNUAL GENERAL MEETING
Publisher：
05-29
2026
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTOR WHO HAS SERVED MORE THAN ...
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Stock Information
02186.HK
Volume：130,198,500
1.97
0.14  (7.65%)
Announcement & Circular
06-16
2026
VOLUNTARY ANNOUNCEMENT THE PHASE 2 CLINICAL TRIAL IN CHINA OF THE GROUP'S NEW DRUG LY03015 (A VMAT2 INHIBITOR/SIGMA-1R AGONIST) FOR THE TREATMENT OF TARDIVE DYSKINESIA HAS ACHIEVED POSITIVE RESULTS
06-11
2026
COMPLETION OF CONCURRENT REPURCHASE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028
06-11
2026
COMPLETION OF ISSUE OF US$180,000,000 5.25 PER CENT. CONVERTIBLE BONDS DUE 2031
06-08
2026
OVERSEAS REGULATORY ANNOUNCEMENT
06-04
2026
(1) PROPOSED CONCURRENT REPURCHASE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028; AND (2) PROPOSED ISSUE OF US$180,000,000 5.25 PER CENT. CONVERTIBLE BONDS DUE 2031
06-03
2026
(1) PROPOSED CONCURRENT REPURCHASE OF US$180,000,000 6.25 PER CENT. CONVERTIBLE BONDS DUE 2028; AND (2) PROPOSED ISSUE OF USD-DENOMINATED CONVERTIBLE BONDS
06-03
2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
05-29
2026
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 26 JUNE 2026
05-29
2026
NOTICE OF ANNUAL GENERAL MEETING
05-29
2026
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTOR WHO HAS SERVED MORE THAN NINE YEARS ON THE BOARD AND RE-APPOINTMENT OF AUDITORS AND NOTICE OF ANNUAL GE
First
1
2
3
4
5
Last